IL149567A0 - Stable salts of novel derivatives of 3,3-diphenylpropylamines - Google Patents

Stable salts of novel derivatives of 3,3-diphenylpropylamines

Info

Publication number
IL149567A0
IL149567A0 IL14956700A IL14956700A IL149567A0 IL 149567 A0 IL149567 A0 IL 149567A0 IL 14956700 A IL14956700 A IL 14956700A IL 14956700 A IL14956700 A IL 14956700A IL 149567 A0 IL149567 A0 IL 149567A0
Authority
IL
Israel
Prior art keywords
new
diphenylpropylamines
novel derivatives
stable salts
salts
Prior art date
Application number
IL14956700A
Other languages
English (en)
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7929277&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL149567(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of IL149567A0 publication Critical patent/IL149567A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Luminescent Compositions (AREA)
IL14956700A 1999-11-16 2000-11-15 Stable salts of novel derivatives of 3,3-diphenylpropylamines IL149567A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19955190A DE19955190A1 (de) 1999-11-16 1999-11-16 Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen
PCT/EP2000/011309 WO2001035957A1 (de) 1999-11-16 2000-11-15 Stabile salze neuartiger derivate von 3,3-diphenylpropylaminen

Publications (1)

Publication Number Publication Date
IL149567A0 true IL149567A0 (en) 2002-11-10

Family

ID=7929277

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14956700A IL149567A0 (en) 1999-11-16 2000-11-15 Stable salts of novel derivatives of 3,3-diphenylpropylamines
IL149567A IL149567A (en) 1999-11-16 2002-05-09 Stable salts of derivatives 3,3 - diphenylpropylamines

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL149567A IL149567A (en) 1999-11-16 2002-05-09 Stable salts of derivatives 3,3 - diphenylpropylamines

Country Status (30)

Country Link
US (1) US6858650B1 (el)
EP (3) EP1481964B1 (el)
JP (6) JP4083431B2 (el)
KR (2) KR100536095B1 (el)
CN (1) CN1215045C (el)
AT (3) ATE395056T1 (el)
AU (1) AU778132B2 (el)
BR (1) BRPI0015610C1 (el)
CA (1) CA2389749C (el)
CY (2) CY1106204T1 (el)
CZ (2) CZ302967B6 (el)
DE (5) DE29923134U1 (el)
DK (3) DK1481964T3 (el)
EA (1) EA005588B1 (el)
ES (3) ES2270240T3 (el)
GE (1) GEP20084430B (el)
HK (3) HK1067114A1 (el)
HU (2) HU228197B1 (el)
IL (2) IL149567A0 (el)
IS (2) IS2124B (el)
MX (1) MXPA02004603A (el)
NO (2) NO323920B1 (el)
NZ (1) NZ519230A (el)
PL (1) PL201422B1 (el)
PT (3) PT1481964E (el)
SI (3) SI1690536T1 (el)
SK (3) SK288185B6 (el)
UA (2) UA73324C2 (el)
WO (1) WO2001035957A1 (el)
ZA (1) ZA200203315B (el)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE29923134U1 (de) * 1999-11-16 2000-06-29 Schwarz Pharma Ag, 40789 Monheim Stabile Salze neuartiger Derviate von 3,3-Diphenylpropylaminen
DE10028443C1 (de) * 2000-06-14 2002-05-29 Sanol Arznei Schwarz Gmbh Verfahren zur Herstellung von 3,3-Diarylpropylaminen, (R,S)- und (R)-4-Phenyl-2-chromanon-6-carbonsäure sowie (R)-4-Phenyl-2-chromanon-carbonsäure-cinchonidinsalz und deren Verwendung zur Herstellung eines rechtsdrehenden Hydroxybenzylalkohols und von pharmazeutischen Zusammensetzungen
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
DE10315878B4 (de) 2003-04-08 2009-06-04 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Fesoterodin und Verwendung
WO2005012227A2 (en) * 2003-08-05 2005-02-10 Ranbaxy Laboratories Limited Process for preparation of 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, a metabolite of tolterodine
ES2235648B1 (es) * 2003-12-22 2006-11-01 Ragactives, S.L. Procedimiento para la obtencion de tolterodina.
US8034823B2 (en) * 2005-02-22 2011-10-11 Savvipharm Inc Method of increasing drug oral bioavailability and compositions of less toxic orotate salts
KR100647068B1 (ko) 2005-09-15 2006-11-23 하나제약 주식회사 라세믹ｎ,ｎ-디이소프로필-3-(2-히드록시-5-메틸페닐)-3-페닐프로판아민의 제조방법
CA2651978C (en) * 2006-05-24 2011-06-07 Pfizer Limited Process for the production of benzopyran-2-ol derivatives
MX2008015233A (es) * 2006-05-31 2008-12-12 Schwarz Pharma Ltd Sintesis nueva de fenoles de hidroximetileno subtituidos.
EP1862449A1 (en) * 2006-05-31 2007-12-05 Schwarz Pharma Ltd. A shortened synthesis of substituted hydroxymethyl phenols
IES20060424A2 (en) * 2006-06-08 2007-10-31 Schwarz Pharma Ltd Accelerated synthesis of (3-Diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenol and its phenolic monoesters
US7807715B2 (en) 2006-06-09 2010-10-05 Ucb Pharma Gmbh Pharmaceutical compositions comprising fesoterodine
US7985873B2 (en) 2006-06-09 2011-07-26 Ucb Pharma Gmbh Synthesis of phenolic esters of hydroxymethyl phenols
RS51973B (en) * 2006-06-09 2012-02-29 Ucb Pharma Gmbh. STABLE PHARMACEUTICAL PRODUCTS CONTAINING FEZOTERODINE
IES20060435A2 (en) 2006-06-12 2007-12-12 Schwarz Pharma Ltd Shortened synthesis using paraformaldehyde or trioxane
DK2027103T3 (da) 2006-06-12 2014-04-22 Ucb Pharma Gmbh Nyt chiralt mellemprodukt, fremgangsmåde til fremstilling deraf og dets anvendelse i fremstillingen af tolterodin, fesoterodin, eller den aktive metabolit deraf
US20100217034A1 (en) * 2007-09-21 2010-08-26 Actavis Group Ptc Ehf Process for the Preparation of Fesoterodine
WO2009044278A1 (en) * 2007-10-01 2009-04-09 Actavis Group Ptc Ehf Amorphous fesoterodine fumarate
EP2294047A2 (en) * 2008-04-04 2011-03-16 Actavis Group PTC EHF Novel mandelate salt of fesoterodine
US20110171274A1 (en) * 2008-07-21 2011-07-14 Actavis Group Ptc Ehf Fesoterodine Substantially Free of Dehydroxy Impurity
IT1392082B1 (it) * 2008-12-10 2012-02-09 Chemi Spa Nuove forme solide della fesoterodina fumarato
KR20120014583A (ko) 2009-05-11 2012-02-17 라티오팜 게엠베하 타르타르산 염 형태의 데스페소테로딘
IT1394217B1 (it) 2009-05-15 2012-06-01 Chemi Spa Metodo di preparazione di fesoterodina e/o fesoterodina fumarato.
IT1394219B1 (it) * 2009-05-15 2012-06-01 Chemi Spa Metodo di preparazione di fesoterodina fumarato di elevata purezza.
KR20120053027A (ko) 2009-09-03 2012-05-24 테바 기오기스제르갸르 자르트쾨렌 뮈쾨되 레스즈베니타르사사그 페소테로딘 푸마레이트 및 페소테로딘 염기의 결정형
IT1396373B1 (it) * 2009-10-29 2012-11-19 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina.
EP2316432A1 (de) 2009-10-30 2011-05-04 ratiopharm GmbH Zusammensetzung enthaltend Fesoterodin und Ballaststoffe
US20110124903A1 (en) * 2009-11-20 2011-05-26 Actavis Group Ptc Ehf Solid state forms of fesoterodine intermediates
IT1397521B1 (it) * 2009-12-21 2013-01-16 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina con un basso contenuto di impurezze.
IT1397920B1 (it) * 2010-02-08 2013-02-04 Dipharma Francis Srl Forma cristallina di fesoterodina fumarato e procedimento per la sua preparazione
US20130172411A1 (en) 2010-03-22 2013-07-04 Cadila Healthcare Limited Stable pharmaceutical compositions comprising fesoterodine
WO2011137054A1 (en) 2010-04-30 2011-11-03 Merck Sharp & Dohme Corp. Novel beta 3 adrenergic receptor agonists
WO2011141932A2 (en) 2010-05-11 2011-11-17 Intas Pharmaceuticals Limited Process for preparation of phenolic monoesters of hydroxymethyl phenols
WO2011145019A1 (en) * 2010-05-17 2011-11-24 Orchid Chemicals And Pharmaceuticals Limited Improved process for diphenylpropylamine derivatives
IT1401451B1 (it) 2010-06-10 2013-07-26 Chemi Spa Nuovo processo di preparazione di 2-idrossi-4-fenil-3,4-diidro-2h-cromen-6-il-metanolo e (r)-2-[3-(diisopropilammino)-1-fenilpropil]-4-(idrossimetil)fenolo.
WO2011158257A1 (en) 2010-06-18 2011-12-22 Panacea Biotec Ltd Preparation process of fesoterodine and intermediates
US9012678B2 (en) * 2010-08-25 2015-04-21 Cadila Healthcare Limited Processes for the preparation of fesoterodine
IT1403094B1 (it) * 2010-12-09 2013-10-04 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina o un suo sale
WO2012098560A2 (en) * 2011-01-17 2012-07-26 Msn Laboratories Limited Process for the preparation of muscarinic receptor antagonist
TWI520732B (zh) 2011-01-18 2016-02-11 輝瑞有限公司 固體分子分散液
EP2508173A1 (en) 2011-04-08 2012-10-10 LEK Pharmaceuticals d.d. Stabilized pharmaceutical composition comprising fesoterodine
EP2508175A1 (en) 2011-04-08 2012-10-10 LEK Pharmaceuticals d.d. Pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
CA2873721C (en) 2012-05-04 2021-06-22 Crystal Pharma, S.A.U. Process for the preparation of optically active 3,3-diphenylpropylamines
ITMI20121232A1 (it) 2012-07-16 2014-01-17 Cambrex Profarmaco Milano Srl Procedimento per la preparazione di 2-(3-n,n-diisopropilamino-1-fenilpropil)-4-idrossimetil-fenolo e suoi derivati
TR201721437A2 (tr) 2017-12-25 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari
CN116472262A (zh) * 2020-10-27 2023-07-21 威娜德国有限责任公司 化妆品级品质的2-甲氧基甲基-对苯二胺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT73982B (en) * 1980-11-14 1983-11-23 Lilly Co Eli Process for preparing 3-aryloxy-3-phenylpropylamines
IL66831A0 (en) * 1981-10-05 1982-12-31 Kefalas As Indane derivatives
SE8800207D0 (sv) * 1988-01-22 1988-01-22 Kabivitrum Ab Nya aminer, deras anvendning och framstellning
ATE140213T1 (de) * 1990-03-08 1996-07-15 Fujisawa Pharmaceutical Co N-monosubstituierte cyclopentenylamine, ein verfahren zu ihrer herstellung, und ihre verwendung als medikament
JPH0483431A (ja) * 1990-07-26 1992-03-17 Seiko Epson Corp 選択呼出受信機
SE9203318D0 (sv) 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
SE9701144D0 (sv) * 1997-03-27 1997-03-27 Pharmacia & Upjohn Ab Novel compounds, their use and preparation
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE29923134U1 (de) * 1999-11-16 2000-06-29 Schwarz Pharma Ag, 40789 Monheim Stabile Salze neuartiger Derviate von 3,3-Diphenylpropylaminen

Also Published As

Publication number Publication date
JP4083431B2 (ja) 2008-04-30
CZ20021343A3 (cs) 2002-09-11
KR100536095B1 (ko) 2005-12-12
AU2666701A (en) 2001-05-30
BRPI0015610B1 (pt) 2016-04-19
JP2010180243A (ja) 2010-08-19
DK1690536T3 (da) 2008-09-01
EP1230209B1 (de) 2005-01-12
PT1481964E (pt) 2006-12-29
SK6572002A3 (en) 2002-12-03
SI1230209T1 (en) 2005-06-30
BRPI0015610C1 (pt) 2021-05-25
PL201422B1 (pl) 2009-04-30
EA200200511A1 (ru) 2002-10-31
JP2011148824A (ja) 2011-08-04
EP1690536A2 (de) 2006-08-16
DE50013365D1 (de) 2006-10-05
JP5650924B2 (ja) 2015-01-07
KR20050100711A (ko) 2005-10-19
DE19955190A1 (de) 2001-06-21
EP1690536B1 (de) 2008-05-14
EP1481964B1 (de) 2006-08-23
EP1230209A2 (de) 2002-08-14
CN1390194A (zh) 2003-01-08
CA2389749C (en) 2009-03-31
EP1230209B3 (de) 2011-10-05
ATE395056T1 (de) 2008-05-15
BR0015610A (pt) 2002-07-30
AU778132B2 (en) 2004-11-18
BR0015610B8 (pt) 2017-10-31
IS2124B (is) 2006-07-14
HUP0204034A3 (en) 2004-12-28
NO20065380L (no) 2002-05-15
IS8382A (is) 2006-03-29
DK1230209T3 (da) 2005-05-30
JP5503393B2 (ja) 2014-05-28
ZA200203315B (en) 2003-09-23
EA005588B1 (ru) 2005-04-28
SI1690536T1 (sl) 2008-08-31
SK288185B6 (sk) 2014-04-02
CY1110389T1 (el) 2015-04-29
HU0900587D0 (en) 2009-11-30
PL356766A1 (en) 2004-07-12
DE50009239D1 (de) 2005-02-17
EP1481964A1 (de) 2004-12-01
WO2001035957A3 (de) 2001-12-27
ES2236032T7 (es) 2012-06-14
HK1067114A1 (en) 2005-04-01
CA2389749A1 (en) 2001-05-25
ATE286872T1 (de) 2005-01-15
JP2003514018A (ja) 2003-04-15
HUP0900587A3 (en) 2010-04-28
US6858650B1 (en) 2005-02-22
JP2007137895A (ja) 2007-06-07
CY1106204T1 (el) 2011-06-08
KR100563149B1 (ko) 2006-03-21
PT1690536E (pt) 2008-07-14
CZ302967B6 (cs) 2012-01-25
SK287430B6 (sk) 2010-09-07
DE29923134U1 (de) 2000-06-29
NO323920B1 (no) 2007-07-23
HK1045148A1 (en) 2002-11-15
JP2010180242A (ja) 2010-08-19
WO2001035957A8 (de) 2001-06-21
CN1215045C (zh) 2005-08-17
HUP0204034A2 (hu) 2003-03-28
HK1095736A1 (en) 2007-05-18
HU227608B1 (en) 2011-09-28
HK1045148B (zh) 2005-05-06
PT1230209E (pt) 2005-05-31
HU228197B1 (en) 2013-01-28
SK288384B6 (sk) 2016-08-01
JP5717824B2 (ja) 2015-05-13
DE50015163D1 (de) 2008-06-26
IS6351A (is) 2002-04-19
JP5290351B2 (ja) 2013-09-18
IS2673B (is) 2010-09-15
NO332637B1 (no) 2012-11-26
ES2303708T3 (es) 2008-08-16
NO20022314L (no) 2002-05-15
DK1481964T3 (da) 2006-11-27
ATE337293T1 (de) 2006-09-15
GEP20084430B (el) 2008-07-25
ES2236032T3 (es) 2005-07-16
UA77322C2 (en) 2006-11-15
JP2014111589A (ja) 2014-06-19
ES2270240T3 (es) 2007-04-01
WO2001035957A1 (de) 2001-05-25
EP1690536A3 (de) 2006-08-23
IL149567A (en) 2007-08-19
CZ302497B6 (cs) 2011-06-15
NZ519230A (en) 2004-11-26
SI1481964T1 (sl) 2006-12-31
UA73324C2 (uk) 2005-07-15
NO20022314D0 (no) 2002-05-15
MXPA02004603A (es) 2004-09-10
KR20020059744A (ko) 2002-07-13

Similar Documents

Publication Publication Date Title
HK1045148A1 (en) Stable salts of novel derivatives of 3,3-dipheylpropylamines.
DK0868424T3 (da) 4-Pyrimidinyl- eller 4-pyrazinyl-piperazinyl-phenyloxazolidinonderivater, fremstilling deraf og anvendelse deraf som antibakterielle midler
IL160700A0 (en) 3-substituted-4-pyrimidone derivatives
ES538418A0 (es) Un derivado de indol-3-carboxamida
DE60324685D1 (de) 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin-wiederaufnahme-inhibitoren
DK0390114T3 (da) Undertrykkelse af syntese og udskillelse af parathyroidhormoner med vitamin D3 derivater
PT1311514E (pt) Composicoes com actividade prejudicial para a vasculatura
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
MXPA02003952A (es) Derivados de imidazol como inhibidores de la fosfodieterasa vii.
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
NO985186L (no) Forbindelser med camptothecin-grunnstruktur, isolert fra Mappia foetida, og anvendelse derav som syntoner for nye legemidler samt som terapeutiske midler
WO2002080918A1 (fr) Agent therapeutique ou prophylactique en cas de miction frequente ou d'incontinence urinaire

Legal Events

Date Code Title Description
EXTE Period for filing application for extension order has been extended (section 64p.(4))